Authors


Carrie Jardine

Latest:

Optimizing the Management of TRD

An expert panel shares insight on the future treatment landscape for treatment-resistant depression.


I. Paul Singh, MD

Latest:

Emerging Treatments for Dry Eye Disease

Ophthalmologist experts provide an overview of emerging treatments for dry eye disease.


Laura Periman, MD

Latest:

Novel Treatment and Diagnostics for Dry Eye

Experts discuss strategies for making dry eye care an appealing practice option for optometry students and supporting their success in this specialized field.


Carl Regillo, MD, Thomas Jefferson University School of Medicine

Latest:

Innovative Therapies on the Horizon to Treat AMD

Carl Regillo, MD and Diana Do, MD react to newer therapies being explored for wet AMD and discuss their place in future therapeutic algorithms.


Gideon Hirschfield, PhD, MB BChir

Latest:

The Future of PBC Management, Pipeline Developments

In this video segment, Reau, Trivedi, and Hirschfield discuss pipeline developments and other advances in primary biliary cholangitis they are most looking forward to.


Paul Feuerstadt, MD

Latest:

Restoring Balance with Advanced Fecal Microbiota Transplantation in C. difficile Infections

Dr Paul Feuerstadt joins Dr David Hudesmand and Dr Jordan Axelrad in a discussion about treatment approaches for C difficile infections, and the latest advances in treating recurrent infections with fecal microbiota transplantation.


Adam Friedman, MD, FAAD, The George Washington School of Medicine & Health Sciences

Latest:

COVID-19 and Payor Strategies for Non-Medical Switching

Adam Friedman, MD, FAAD discusses how payors accelerated non-medical switching during COVID-19 and how healthcare providers can respond to new challenges. 


Seenu Hariprasad, MD

Latest:

Perspectives on the Future of Retinal Disease Management

Experts conclude this series highlighting what is on the horizon of retinal disease care.


Robert Busch, MD

Latest:

Protecting Cardiorenal Function In Diabetic Kidney Disease

Dhiren Patel, PharmD, and Bob Busch, MD, interview Fatima Cody Stanford, MD, MPH, MPA, an obesity medicine specialist, to examine the cardiovascular (CV) impact of obesity and delve into the potential benefits of newer weight loss medications in mitigating CV risk and heart failure.



Jayanth Sridhar, MD

Latest:

Advice to Physicians Treating Geographic Atrophy

Drs Eleonora M. Lad, David R. Lally, Jaynath R. Sridhar, and Nancy M. Holekamp share takeaways for health care professionals taking care of patients with geographic atrophy and earlier stages of age-related macular degeneration.


Robin S. Goland, MD

Latest:

Strategies to Improve Screening and Diagnosis of T1D

Drs Robert Busch, Robin S. Goland, Kimberly Simmons, and Teresa Quattrin discuss strategies to facilitate screening of type 1 diabetes and improve management of disease.


Michael Koren, MD, FACC

Latest:

Cardiometabolic Medicine: Seeing the Patient as a Whole

The panelists stress the significance of a comprehensive approach to patient care, acknowledging the interconnected nature of cardiovascular, kidney, endocrine, and obesity-related benefits, and highlighting that addressing secondary diseases can minimize overall disease risk in patients.


David Mannino, MD | Credit: Twitter
David Mannino, MD

Latest:

A Promising Pipeline for COPD

Mannino, Anzueto and Christenson conclude the panel with thoughts on developing biologics for COPD, and increased interest in the field after ensifentrine and dupilumab.



J. Scott Boswell, MD

Latest:

Tips for Managing Generalized Pustular Psoriasis (GPP)

Dermatologists Drs Tina Bhutani and Scott Boswell and patient Kanya Oul share resources and tools available to cope with generalized pustular psoriasis (GPP).


James A. McKinnell, MD

Latest:

Looking Toward the Future of CDI Management

Closing out their discussion on Clostridioides difficile infection, panelists share closing thoughts on novel pipeline therapies.


Marjan Farid, MD

Latest:

Novel Treatment and Diagnostics for Dry Eye

Experts discuss strategies for making dry eye care an appealing practice option for optometry students and supporting their success in this specialized field.


Lawrence F. Eichenfield, MD, Rady Children’s Hospital-San Diego

Latest:

Emerging Agents for the Treatment of Atopic Dermatitis

Lawrence F. Eichenfield, MD; Jeffrey M. Bienstock, MD, FAAP; Peter A. Lio, MD; and Elizabeth A. Swanson, MD, review additional mechanisms being investigated in the pipeline for the treatment of atopic dermatitis.


Barbara Kennedy, MHA, FACHE

Latest:

Leading Through Twin Healthcare Crises

Stress induced by COVID-19 is driving opioid addiction risks. An expert weighs in on addressing one matter to resolve another.



Aparna Goel, MD

Latest:

Differential Diagnosis of PBC

The panel of experts focus on strategies for distinguishing primary biliary cholangitis (PBC) from other liver diseases with similar clinical presentations, emphasizing key diagnostic markers and assessment techniques.


James Januzzi, MD

Latest:

REMS Program Resources for Clinicians

An expert cardiologist discusses the importance of healthcare provider education and finding resources around the REMS program.


Jay Luther, MD | Credit: MGH
Jay Luther, MD

Latest:

Addressing Stigma to Improve Outcomes in Alcohol-Related Liver Disease

The second segment of a special report stresses the importance of cross-specialty collaboration with hepatology and psychiatry when treating alcohol-related liver disease.


Abigail Brooks, MA

Latest:

Marcelo Kugelmas, MD: Elafibranor (Iqirvo) Does Not Impact Renal Function in PBC

Kugelmas reviews findings from a secondary analysis of the phase 3 ELATIVE trial suggesting elafibranor is associated with stable kidney function.



Lauren Miller, MPAS, PA-C

Latest:

Exploring Oral Systemic Therapies For Plaque Psoriasis: Efficacy, Safety, and Clinical Considerations

Lauren Miller, MPAS, PA-C; Jayme M. Heim, MSN FNP-BC, and Kirk Gautier, PA-C, discuss recent advancements in plaque psoriasis treatment, focusing on novel oral systemic therapies like the TYK-2 inhibitor deucravacitinib and its clinical trial data, to inform therapeutic decisions for this systemic disease.


Sagar V Parikh, MD, FRCPC

Latest:

Improving Awareness for Depressive Disorders

Andrew J Cutler, MD; Gregory Mattingly, MD; and Sagar V. Parikh, MD, FRCPC, comment on the need to improve awareness around depressive disorders and break the stigma of mental health treatment.


Kimberly A. Brown, MD

Latest:

Refractory Encephalopathy, Multivitamins and Closing Thoughts

Medical experts share insights on managing refractory hepatic encephalopathy and provide concluding remarks and essential points on the condition.


© 2024 MJH Life Sciences

All rights reserved.